Soleno Therapeutics (6XC.F) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.22
-0.68
-0.13
0.41

Details

Expected EPS
0.05006295
Actual EPS
0.40921019999999997
Surprise EPS
0.36
Surprise Percent
+717.39%

Description

Soleno Therapeutics (6XC.F) has reported earnings of 0.40921019999999997 per share for Q4 2025.

0 Comments

Share your thoughts